Skip to main content
Erschienen in: Inflammation Research 9/2014

01.09.2014 | Original Research Paper

Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo

verfasst von: Soyoung Kwak, Sae-Kwang Ku, Jong-Sup Bae

Erschienen in: Inflammation Research | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Aim and objective

Fisetin, an active compound isolated from flowering plants in the family Fabaceae, was reported to have antiviral, neuroprotective, and anti-inflammatory effects. Vascular inflammatory processes have been suggested to play key roles in the initiation and progression of atherosclerosis, a major complication of diabetes mellitus. Thus, we determined the ability of fisetin to suppress vascular inflammatory processes induced by high glucose (HG) in primary human umbilical vein endothelial cells (HUVECs) and mice.

Methods

The effects of fisetin on HG-induced vascular inflammation were determined by measuring vascular permeability, leukocyte adhesion and migration, cell adhesion molecule (CAM) expression levels, reactive oxygen species (ROS) formation, and nuclear factor (NF)-κB activation.

Results

HG markedly increased vascular permeability, monocyte adhesion, expressions of CAMs, formation of ROS, and activation of NF-κB. Remarkably, all of the observed vascular inflammatory effects induced by HG were inhibited by pretreatment with fisetin.

Conclusion

Vascular inflammatory responses induced by HG are critical events underlying the development of diabetic complications; therefore, our results suggest that fisetin possesses significant therapeutic effects against diabetic complications and atherosclerosis.
Literatur
1.
Zurück zum Zitat Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.PubMedCrossRef Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.PubMedCrossRef
2.
Zurück zum Zitat Thomas JE, Foody JM. The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. J Cardiometab Syndr. 2007;2:108–13.PubMedCrossRef Thomas JE, Foody JM. The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy. J Cardiometab Syndr. 2007;2:108–13.PubMedCrossRef
3.
Zurück zum Zitat Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130–5.PubMedCrossRef Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, Nag S, et al. The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care. 2005;28:2130–5.PubMedCrossRef
4.
Zurück zum Zitat Holman R, Turner R (1991) Textbook of diabetes. Oxford: Blackwell. Holman R, Turner R (1991) Textbook of diabetes. Oxford: Blackwell.
5.
Zurück zum Zitat Li GQ, Kam A, Wong KH, Zhou X, Omar EA, Alqahtani A, et al. Herbal medicines for the management of diabetes. Adv Exp Med Biol. 2012;771:396–413.PubMed Li GQ, Kam A, Wong KH, Zhou X, Omar EA, Alqahtani A, et al. Herbal medicines for the management of diabetes. Adv Exp Med Biol. 2012;771:396–413.PubMed
6.
Zurück zum Zitat Day C. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. Br J Nutr. 1998;80:5–6.PubMedCrossRef Day C. Traditional plant treatments for diabetes mellitus: pharmaceutical foods. Br J Nutr. 1998;80:5–6.PubMedCrossRef
7.
Zurück zum Zitat Gerrity RG. The role of the monocyte in atherogenesis: I. transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181–90.PubMedCentralPubMed Gerrity RG. The role of the monocyte in atherogenesis: I. transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol. 1981;103:181–90.PubMedCentralPubMed
8.
Zurück zum Zitat Wardle EN. Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract. 1994;23:135–9.PubMedCrossRef Wardle EN. Vascular permeability in diabetics and implications for therapy. Diabetes Res Clin Pract. 1994;23:135–9.PubMedCrossRef
9.
Zurück zum Zitat Esposito C, Fasoli G, Plati AR, Bellotti N, Conte MM, Cornacchia F, et al. Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int. 2001;59:1842–9.PubMedCrossRef Esposito C, Fasoli G, Plati AR, Bellotti N, Conte MM, Cornacchia F, et al. Long-term exposure to high glucose up-regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int. 2001;59:1842–9.PubMedCrossRef
10.
Zurück zum Zitat Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis. 2002;162:277–87.PubMedCrossRef Hamuro M, Polan J, Natarajan M, Mohan S. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis. 2002;162:277–87.PubMedCrossRef
11.
Zurück zum Zitat Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest. 1998;101:1905–15.PubMedCentralPubMedCrossRef Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, et al. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion. J Clin Invest. 1998;101:1905–15.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Tooke JE. Microvascular function in human diabetes a physiological perspective. Diabetes. 1995;44:721–6.PubMedCrossRef Tooke JE. Microvascular function in human diabetes a physiological perspective. Diabetes. 1995;44:721–6.PubMedCrossRef
13.
Zurück zum Zitat Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care. 1995;18:1–9.PubMedCrossRef Nannipieri M, Rizzo L, Rapuano A, Pilo A, Penno G, Navalesi R. Increased transcapillary escape rate of albumin in microalbuminuric type II diabetic patients. Diabetes Care. 1995;18:1–9.PubMedCrossRef
14.
Zurück zum Zitat Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin.Therapeutic Targets. 2006;10:87–118.CrossRef Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin.Therapeutic Targets. 2006;10:87–118.CrossRef
15.
Zurück zum Zitat Bae JS. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res. 2012;35:1511–23.PubMedCrossRef Bae JS. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res. 2012;35:1511–23.PubMedCrossRef
16.
Zurück zum Zitat Middleton E Jr, Drzewiecki G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol. 1984;33:3333–8.PubMedCrossRef Middleton E Jr, Drzewiecki G. Flavonoid inhibition of human basophil histamine release stimulated by various agents. Biochem Pharmacol. 1984;33:3333–8.PubMedCrossRef
17.
Zurück zum Zitat Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000;72:391–8.PubMed Mukaida N. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol. 2000;72:391–8.PubMed
18.
Zurück zum Zitat Hirano T, Higa S, Arimitsu J, Naka T, Ogata A, Shima Y, et al. Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem Biophys Res Commun. 2006;340:1–7.PubMedCrossRef Hirano T, Higa S, Arimitsu J, Naka T, Ogata A, Shima Y, et al. Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem Biophys Res Commun. 2006;340:1–7.PubMedCrossRef
19.
Zurück zum Zitat Bakay M, Mucsi I, Beladi I, Gabor M. Effect of flavonoids and related substances. II. Antiviral effect of quercetin, dihydroquercetin and dihydrofisetin. Acta Microbiol Acad Sci Hung. 1968;15:223–7.PubMed Bakay M, Mucsi I, Beladi I, Gabor M. Effect of flavonoids and related substances. II. Antiviral effect of quercetin, dihydroquercetin and dihydrofisetin. Acta Microbiol Acad Sci Hung. 1968;15:223–7.PubMed
20.
Zurück zum Zitat Sung B, Pandey MK, Aggarwal BB. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation. Mol Pharmacol. 2007;71:1703–14.PubMedCrossRef Sung B, Pandey MK, Aggarwal BB. Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappaB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IkappaBalpha kinase activation. Mol Pharmacol. 2007;71:1703–14.PubMedCrossRef
21.
Zurück zum Zitat Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, et al. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci Lett. 2008;444:280–5.PubMedCrossRef Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, et al. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci Lett. 2008;444:280–5.PubMedCrossRef
22.
Zurück zum Zitat Lee W, Ku SK, Bae JS. Emodin-6-O-beta-d-glucoside down-regulates endothelial protein C receptor shedding. Arch Pharm Res. 2013;36:1160–5.PubMedCrossRef Lee W, Ku SK, Bae JS. Emodin-6-O-beta-d-glucoside down-regulates endothelial protein C receptor shedding. Arch Pharm Res. 2013;36:1160–5.PubMedCrossRef
23.
Zurück zum Zitat Bae JS, Rezaie AR. Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Rep. 2013;46:544–9.PubMedCrossRef Bae JS, Rezaie AR. Thrombin inhibits HMGB1-mediated proinflammatory signaling responses when endothelial protein C receptor is occupied by its natural ligand. BMB Rep. 2013;46:544–9.PubMedCrossRef
24.
Zurück zum Zitat Bae JS, Lee W, Rezaie AR. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost. 2012;10(6):1145–51.PubMedCentralPubMedCrossRef Bae JS, Lee W, Rezaie AR. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost. 2012;10(6):1145–51.PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, et al. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol. 2009;9:268–76.PubMedCrossRef Lee JD, Huh JE, Jeon G, Yang HR, Woo HS, Choi DY, et al. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol. 2009;9:268–76.PubMedCrossRef
26.
Zurück zum Zitat Akeson AL, Woods CW. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods. 1993;163:181–5.PubMedCrossRef Akeson AL, Woods CW. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods. 1993;163:181–5.PubMedCrossRef
27.
Zurück zum Zitat Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2001;276:7614–20.PubMedCrossRef Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2001;276:7614–20.PubMedCrossRef
28.
Zurück zum Zitat Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991;174:1517–26.PubMedCrossRef Mackman N, Brand K, Edgington TS. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites. J Exp Med. 1991;174:1517–26.PubMedCrossRef
29.
Zurück zum Zitat Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937–42.PubMedCrossRef Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937–42.PubMedCrossRef
30.
Zurück zum Zitat Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–8.PubMedCrossRef Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–8.PubMedCrossRef
31.
Zurück zum Zitat Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh). 1994;72:553–9.CrossRef Sander B, Larsen M, Engler C, Lund-Andersen H, Parving HH. Early changes in diabetic retinopathy: capillary loss and blood-retina barrier permeability in relation to metabolic control. Acta Ophthalmol (Copenh). 1994;72:553–9.CrossRef
32.
Zurück zum Zitat Lopes-Virella MF, Virella G. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes. 1992;41(Suppl 2):86–91.PubMedCrossRef Lopes-Virella MF, Virella G. Immune mechanisms of atherosclerosis in diabetes mellitus. Diabetes. 1992;41(Suppl 2):86–91.PubMedCrossRef
33.
Zurück zum Zitat Kado S, Wakatsuki T, Yamamoto M, Nagata N. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci. 2001;68:727–37.PubMedCrossRef Kado S, Wakatsuki T, Yamamoto M, Nagata N. Expression of intercellular adhesion molecule-1 induced by high glucose concentrations in human aortic endothelial cells. Life Sci. 2001;68:727–37.PubMedCrossRef
34.
Zurück zum Zitat Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–19.PubMedCrossRef Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–19.PubMedCrossRef
35.
Zurück zum Zitat Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med. 2004;14:161–5.PubMedCrossRef Boisvert WA. Modulation of atherogenesis by chemokines. Trends Cardiovasc Med. 2004;14:161–5.PubMedCrossRef
36.
Zurück zum Zitat Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939–45.PubMedCrossRef Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939–45.PubMedCrossRef
37.
Zurück zum Zitat Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl. 2000;77:S3–12.PubMedCrossRef Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl. 2000;77:S3–12.PubMedCrossRef
38.
Zurück zum Zitat Han HJ, Lee YJ, Park SH, Lee JH, Taub M. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol. 2005;288:F988–96.PubMedCrossRef Han HJ, Lee YJ, Park SH, Lee JH, Taub M. High glucose-induced oxidative stress inhibits Na+/glucose cotransporter activity in renal proximal tubule cells. Am J Physiol Renal Physiol. 2005;288:F988–96.PubMedCrossRef
39.
Zurück zum Zitat Rimbach G, Valacchi G, Canali R, Virgili F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun. 2000;3:238–42.PubMedCrossRef Rimbach G, Valacchi G, Canali R, Virgili F. Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun. 2000;3:238–42.PubMedCrossRef
40.
Zurück zum Zitat Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res. 2001;88:1291–8.PubMedCrossRef Uemura S, Matsushita H, Li W, Glassford AJ, Asagami T, Lee KH, et al. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res. 2001;88:1291–8.PubMedCrossRef
Metadaten
Titel
Fisetin inhibits high-glucose-induced vascular inflammation in vitro and in vivo
verfasst von
Soyoung Kwak
Sae-Kwang Ku
Jong-Sup Bae
Publikationsdatum
01.09.2014
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 9/2014
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-014-0750-4

Weitere Artikel der Ausgabe 9/2014

Inflammation Research 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Neue S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Schadet Ärger den Gefäßen?

14.05.2024 Arteriosklerose Nachrichten

In einer Studie aus New York wirkte sich Ärger kurzfristig deutlich negativ auf die Endothelfunktion gesunder Probanden aus. Möglicherweise hat dies Einfluss auf die kardiovaskuläre Gesundheit.

Intervallfasten zur Regeneration des Herzmuskels?

14.05.2024 Herzinfarkt Nachrichten

Die Nahrungsaufnahme auf wenige Stunden am Tag zu beschränken, hat möglicherweise einen günstigen Einfluss auf die Prognose nach akutem ST-Hebungsinfarkt. Darauf deutet eine Studie an der Uniklinik in Halle an der Saale hin.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.